Transcript Document

Biotechnology/Chemical/Pharmaceutical
Customer Partnership Meeting
October 8, 2002
William F. Smith
Administrative Patent Judge
Board of Patent Appeals and Interferences
Biotechnology Division
Ex parte Administrative Patent Judges
Donald Adams
Eric Grimes
Toni Scheiner
Sherman Winters
Lora Green
Demetra Mills
William Smith
Biotechnology Division
Support Team
Dianne Maggard, Paralegal Specialist
Phone Number 703 305-4673
Dionne Murphy and JoAnne Burke, Legal Technicians
Lisa Bean and Marrilyn Johnson, Legal Instrument
Examiners
Facsimile Number 703 308-6200
‘
The Board’s goal is to have no more than a six
month inventory of ex parte appeals pending
decision by September 30, 2003.
The Biotechnology Division is on track to meet
that goal.
Case Load
As of October 1, 2002, all pre-2001-XXXX
biotechnology appeals available for decision
have been decided.
As of October 1, 2002, the Biotechnology
Division had 324 cases on APJ’s dockets
awaiting decision (on brief and cases which
have been heard and awaiting decision) and
85 cases waiting to be heard.
Hearings
Hearing notices will be mailed 3-5 months
ahead of date
After confirmations/waivers are received in
initial set of cases, notices will be mailed in a
second set of cases
Goal is to have at least 3 cases confirmed for
each session
Hearings
Special hearings will be scheduled as needed
and are normally scheduled by way of
telephone.
Requests for rescheduling hearings should be
made with an earlier date in mind.
Role of the Board
“The [Board] shall, on written appeal of an
applicant, review adverse decisions of
examiners upon applications for patents …”
35 U.S.C. § 6(b)(emphasis added)
In other words, the Board serves as a board of
review, not as a de novo examination
tribunal.
How can you assist in preparing a record which will
facilitate a meaningful review of the examiner’s
decision?
Has prosecution/examination been conducted
on the basis of determining the patentability
of individual claims?
Or have the examiner’s actions and your
responses been based upon “The invention,”
“Applicant’s invention,” “The instant invention”
etc.
Record
Focus must begin and remain on the claims
“[T]he name of the game is the claim.” In re
Hiniker Co., 47 USPQ2d 1523, 1529 (Fed.
Cir. 1998)
The sooner counsel and the examiner are
discussing the patentability of individual
claims, the sooner the patentability issues will
be resolved.
Record cont’d
Remember claim construction in the USPTO
differs from claim construction in an
enforcement action.
“[A]s an initial matter the PTO applies to the verbiage
of the proposed claims the broadest reasonable
meaning of the words in their ordinary usage as they
would be understood by one of ordinary skill in the
art, taking into account whatever enlightenment by
way of definitions or otherwise that may be afforded
by the written description contained the applicant’s
specification.”
In re Morris, 127 F.3d 1048, 1054, 44 USPQ2d 1023,
1027 (Fed. Cir. 1997)
Record cont’d
Has prosecution/examination been based upon
the most complete set of facts available?
Are abstracts and/or untranslated documents
relied upon by you or the examiner?
Rely upon source documents, translated if
needed, at the earliest point in the
examination process.
Record cont’d
Have formal matters been completed?
All petitions been decided?
Do you have a clear understanding of the status
of all claims and the entry of all amendments
after final rejection?
Record cont’d
Has all prior art of record been properly
evaluated by you and the examiner?
The majority of panel remands to examiners
and new rejections under 37 CFR § 1.196(b)
involve prior art of record.
Record cont’d
Has all the evidence you intend to rely upon in
the appeal been entered and considered by
the examiner?
“Affidavits, declarations, or exhibits submitted
after the case has been appealed will not be
admitted without a showing of good and
sufficient reasons why they were not earlier
presented.”
37 CFR § 1. 195
Appeal Brief
The formal requirements of the Appeal Brief are
set forth in 37 CFR § 1.192. See also MPEP
Chapter 1200.
In preparing your Appeal Brief be aware that a
mandatory appeal conference will be held in
the Technical Center before an Examiner’s
Answer is authorized.
Appeal Brief
Brief must contain your complete position.
“Any arguments or authorities not included in
the brief will be refused consideration by the
Board of Patent Appeals and Interferences,
unless good cause is shown.”
37 CFR § 1.192(a)
Remember requirements of 37 CFR § 1.195
Appeal Brief
Summary of Invention
Focus on the requirements of individual
claims. Be specific with references to
specification and drawings to aid the reader in
understanding the claims.
Appeal Brief
Separate argument of claims
Separate argument of claims
1. If appropriate, simply state “Claims do not
stand or fall together.”
2. For every rejection, use headings in
“Argument” section of brief to highlight
argument.
Appeal Brief
Separate argument of claims, cont’d
For example in the “Argument” section a series
of headings such as these can be used for
each rejection:
I. Arguments in response to enablement
rejection.
A. Separate argument for claim 1.
B. Claims 2-3 are patentable for
the reasons claim 1 is patentable.
C. Separate argument for claim 4.
Reply Brief
Two reasons to file
Point to arguments set forth in the Appeal
Brief which the examiner overlooked.
Respond to new points of argument made in
the Examiner’s Answer.
Remember the requirements of 37 CFR § 1.195
Do you know where your case is?
Know where your case is located in the PTO
after the briefing is concluded by using PAIR.
The case should be forwarded to the Board
within two months of the Reply Brief being
acknowledged or the Examiner’s Answer
being mailed if no Reply Brief is timely filed.
MPEP 1210.
Summary
Make sure your case is ready for a decision
on appeal.
 Briefing should be focused on individual
claims.
 Make sure all evidence you need to prove
your case is entered and considered by the
examiner before the appeal.
 Remember that the Board serves as a Board
of review not as a de novo examination
tribunal.
